AaronLeeDO(He/Him)

Hematology/Oncology Fellow, University of Colorado Anschutz Medical Campus

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Hematology/Oncology Fellow at University of Colorado, with special interests in Solid Tumors, medical education, Quality Improvement/Patient Experience, and academic medicine. Former Chief Resident in Quality and Safety at UC San Diego Internal Medicine Residency

University of California (San Diego) Medical CenterResidency, Internal Medicine, 2019 - 2022
College of Osteopathic Medicine of the PacificClass of 2019, D.O.
UC San Diego M.S., Biology , 2012 - 2014
UC San Diego B.S., Molecular biology , 2009 - 2013

PubMed

8 citations
Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.
Aaron M. Lee, Jane C. Burns, Adriana H. Tremoulet
The Pediatric Infectious Disease Journal. 2017-04-01
18 citations
Role of TGF-β Signaling in Remodeling of Noncoronary Artery Aneurysms in Kawasaki Disease:
Aaron M. Lee, Chisato Shimizu, Toshiaki Oharaseki, Kei Takahashi, Lori B. Daniels
Pediatric and Developmental Pathology. 2015-04-09
4 citations
The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer.
Aaron M Lee, Ava Saidian, Justin Shaya, Taylor Nonato, Angelo Cabal
Clinical Genitourinary Cancer. 2022-12-01

Case Series Suggests Venetoclax Plus Hypomethylating Agent Therapy Tolerable, Effective in Very Elderly AML PatientsJuly 4th, 2022

Center for Empathy and Compassion Training in Medical Education: Seed Grant ProgramT. Denny Sanford Institute for Empathy and Compassion UC San Diego2022–2023